Search for: "Wyeth Ayerst Pharmaceuticals Inc"
Results 21 - 40
of 41
Sorted by Relevance
|
Sort by Date
17 Oct 2013, 5:00 am
Mutual Pharmaceutical Co., 731 F. [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
11 Sep 2012, 11:36 am
Novartis Pharmaceutical Corp. [read post]
6 Jul 2007, 4:29 am
Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). [read post]
28 Oct 2011, 7:00 am
Wyeth, Inc., 85 Cal. [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
3 Jun 2010, 1:37 pm
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]
3 Mar 2012, 5:36 pm
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
19 May 2011, 1:15 pm
Wyeth-Ayerst Laboratories Co., 278 F. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
18 Mar 2011, 10:04 am
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
2 Dec 2015, 12:38 pm
Metabolife Int’l, Inc., 401 F.3d 1233, 1241 (11th Cir. 2005) (reversing admission of expert witness’s testimony when the witness conceded a dose-response, but failed to address the dose of the medication needed to cause the claimed harm). [read post]
16 Dec 2010, 1:54 pm
We would all go down together!! [read post]
5 Feb 2009, 12:19 pm
Wyeth-Ayerst Laboratories, was (predictably) a class action for economic loss. [read post]
